川崎病静脉注射免疫球蛋白治疗后迟发性和长期全身性汗疱疹样湿疹 - Suppr

Suppr

超能文献

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.

作者信息

Yokoyama Koji, Yoshida Akira

机构信息

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

出版信息

BMJ Case Rep. 2019 Mar 21;12(3):e229596. doi: 10.1136/bcr-2019-229596.

DOI:10.1136/bcr-2019-229596

PMID:30902846

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6453435/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d66/6453435/3a64f923d6b9/bcr-2019-229596f01.jpg

相似文献

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.

BMJ Case Rep. 2019 Mar 21;12(3):e229596. doi: 10.1136/bcr-2019-229596.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

Dyshidrotic eczema following intravenous immunoglobulin treatment.

CMAJ. 2013 Aug 6;185(11):E530. doi: 10.1503/cmaj.121036. Epub 2012 Dec 3.

Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.

Arch Dermatol. 2006 Feb;142(2):247-8. doi: 10.1001/archderm.142.2.247.

Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.

J Drugs Dermatol. 2003 Jun;2(3):337-41.

Pompholyx induced by intravenous immunoglobulin therapy.

J Investig Allergol Clin Immunol. 2007;17(4):277-8.

Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.

Neurology. 1999 Sep 22;53(5):1154-5. doi: 10.1212/wnl.53.5.1154.

Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.

Dermatol Ther. 2020 Nov;33(6):e14147. doi: 10.1111/dth.14147. Epub 2020 Sep 3.

Dyshidrotic eczema associated with the use of IVIg.

BMJ Case Rep. 2013 Feb 15;2013:bcr2012008001. doi: 10.1136/bcr-2012-008001.

Drug-induced hypersensitivity syndrome by i.v. immunoglobulin administration for Kawasaki disease.

J Dermatol. 2020 Mar;47(3):e74-e75. doi: 10.1111/1346-8138.15211. Epub 2020 Jan 5.

引用本文的文献

Eczematous Drug Eruptions.

Am J Clin Dermatol. 2021 May;22(3):349-366. doi: 10.1007/s40257-021-00586-8. Epub 2021 Feb 15.

本文引用的文献

Dyshydrotic Eczema Secondary to Intravenous Immunoglobulin Infusion: A Report of 2 Cases.

Actas Dermosifiliogr. 2016 Jun;107(5):431-3. doi: 10.1016/j.ad.2015.09.018. Epub 2016 Jan 5.

Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):127-30. doi: 10.1177/039463201402700117.

Adverse effects of IgG therapy.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):558-66. doi: 10.1016/j.jaip.2013.09.012. Epub 2013 Oct 31.

Significant dermatological side effects of intravenous immunoglobulin.

J Clin Neurosci. 2013 Aug;20(8):1114-6. doi: 10.1016/j.jocn.2012.10.026. Epub 2013 May 7.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.

J Am Acad Dermatol. 2012 Feb;66(2):312-6. doi: 10.1016/j.jaad.2010.12.034. Epub 2011 May 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.

BMJ Case Rep. 2019 Mar 21;12(3):e229596. doi: 10.1136/bcr-2019-229596.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

Dyshidrotic eczema following intravenous immunoglobulin treatment.

CMAJ. 2013 Aug 6;185(11):E530. doi: 10.1503/cmaj.121036. Epub 2012 Dec 3.

Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.

Arch Dermatol. 2006 Feb;142(2):247-8. doi: 10.1001/archderm.142.2.247.

Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.

J Drugs Dermatol. 2003 Jun;2(3):337-41.

Pompholyx induced by intravenous immunoglobulin therapy.

J Investig Allergol Clin Immunol. 2007;17(4):277-8.

Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.

Neurology. 1999 Sep 22;53(5):1154-5. doi: 10.1212/wnl.53.5.1154.

Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.

Dermatol Ther. 2020 Nov;33(6):e14147. doi: 10.1111/dth.14147. Epub 2020 Sep 3.

Dyshidrotic eczema associated with the use of IVIg.

BMJ Case Rep. 2013 Feb 15;2013:bcr2012008001. doi: 10.1136/bcr-2012-008001.

Drug-induced hypersensitivity syndrome by i.v. immunoglobulin administration for Kawasaki disease.

J Dermatol. 2020 Mar;47(3):e74-e75. doi: 10.1111/1346-8138.15211. Epub 2020 Jan 5.

引用本文的文献

Eczematous Drug Eruptions.

Am J Clin Dermatol. 2021 May;22(3):349-366. doi: 10.1007/s40257-021-00586-8. Epub 2021 Feb 15.

本文引用的文献

Dyshydrotic Eczema Secondary to Intravenous Immunoglobulin Infusion: A Report of 2 Cases.

Actas Dermosifiliogr. 2016 Jun;107(5):431-3. doi: 10.1016/j.ad.2015.09.018. Epub 2016 Jan 5.

Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):127-30. doi: 10.1177/039463201402700117.

Adverse effects of IgG therapy.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):558-66. doi: 10.1016/j.jaip.2013.09.012. Epub 2013 Oct 31.

Significant dermatological side effects of intravenous immunoglobulin.

J Clin Neurosci. 2013 Aug;20(8):1114-6. doi: 10.1016/j.jocn.2012.10.026. Epub 2013 May 7.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.

J Am Acad Dermatol. 2012 Feb;66(2):312-6. doi: 10.1016/j.jaad.2010.12.034. Epub 2011 May 20.